RxDoctor Payments Data

Sara Blitenthal

Primary Care · Jamaica, NYNPI 1801671706

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.5% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.2% — the pattern of someone who eats at a lot of different presentations.

$1,550in general payments, 2019–2025

Across 72 payments — averaging $21.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$235
  • Lilly USA, LLC$200
  • Astellas Pharma US Inc$144
  • GSK$124
  • AstraZeneca$107
  • Amgen$100
  • plus $640 from 20 others

What the payments were for

  • Food & beverage$1,48196%
  • Education$694%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,550 in reported general payments places this provider in the 80th percentile of 239 primary care providers in New York.

See all primary care providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide15$23,836
JanuviaSitagliptin Phosphate24$21,241
FarxigaDapagliflozin Propanediol11$9,284
Atorvastatin Calcium110$1,145
Albuterol Sulfate HfaAlbuterol Sulfate42$1,125
Lantus SolostarInsulin Glargine,hum.Rec.Anlog13$902
Amlodipine-ValsartanAmlodipine Besylate/Valsartan12$864
Repaglinide25$645
Diclofenac Sodium24$643
Cyanocobalamin InjectionCyanocobalamin (Vitamin B-12)12$553
Tamsulosin Hcl28$450
Amlodipine Besylate89$438
Losartan Potassium62$422
Nifedipine ErNifedipine26$414
Metoprolol Succinate24$353

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$20$23,83615 claims
AstraZenecaFarxiga$107$9,28411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 239 primary care providers in New York.

Other primary care in Jamaica

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →